Evaluating sarcopenia in patients with chronic pancreatitis
SARcopenia in Patients With ChrOnic PANcreatitis: the SARCOPAN Study
NA · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06092307
This study is trying to see how common muscle loss is in people with chronic pancreatitis and how it affects their health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 98 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Roma) |
| Trial ID | NCT06092307 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the prevalence and impact of sarcopenia in patients diagnosed with chronic pancreatitis. It will evaluate whole body composition, dynamic force tests, and laboratory data at various stages of the disease. The study will also investigate the effectiveness of bioimpedance analysis and muscle ultrasound in diagnosing sarcopenia. By understanding the relationship between sarcopenia and chronic pancreatitis, the research seeks to improve patient outcomes and management strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 65 years who have been diagnosed with chronic pancreatitis.
Not a fit: Patients outside the age range of 18 to 65 years or those who cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better diagnosis and management of sarcopenia in patients with chronic pancreatitis, potentially improving their quality of life.
How similar studies have performed: While there is limited evidence specifically linking sarcopenia to chronic pancreatitis, similar studies have shown the importance of assessing sarcopenia in chronic diseases, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * written informed consent * diagnosis of chronic pancreatitis * age between 18 and 65 years, * abdominal CT or MRI into precedent maximum12 months. Exclusion Criteria: * age less than 18 or older than 65 years * lack of informed consent.
Where this trial is running
Roma
- Fondazione Policlinico Gemelli IRCCS — Roma, Italy (RECRUITING)
Study contacts
- Study coordinator: Maria Assunta Zocco
- Email: mariaassunta.zocco@policlinicogemelli.it
- Phone: 00393470597805
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pancreatitis